Amanda Esch
Impact in
-
- Cancer Cells and Metastasis
- Biophysics top 10%
Papers in
-
- DNA Repair Mechanisms 1
- Ubiquitin and proteasome pathways 1
- Oncology 7
- HER2/EGFR in Cancer Research 2
- PARP inhibition in cancer therapy 2
- Co-authors
- N. L. Shipkowitz (3 shared papers)A. Crovetti (4 shared papers)Lacy R. Overby (2 shared papers)J. B. Schleicher (2 shared papers)E Ertürk (3 shared papers)J. M. Price (3 shared papers)William R. Roderick (1 shared paper)Carl W. Nordeen (1 shared paper)
- Journals
- European Journal of Endocrinology (2 papers)Cancer Research (2 papers)Molecular Cancer Therapeutics (1 paper)Protein Expression and Purification (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesUnited KingdomGreece
In The Last Decade
Amanda Esch
20 papers receiving 469 citations
Peers
Comparison fields: 5 of 86
- Oncology 124
- Biophysics 29
- Cancer Research 54
- Epidemiology 110
- Biochemistry 23
Countries citing papers authored by Amanda Esch
This map shows the geographic impact of Amanda Esch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Esch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Esch more than expected).
Fields of papers citing papers by Amanda Esch
This network shows the impact of papers produced by Amanda Esch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Esch. The network helps show where Amanda Esch may publish in the future.
Co-authors
The 25 scholars most cited alongside Amanda Esch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1973 | 106 | |
| 2 | The production of carcinoma of the urinary bladder in rats by feeding N-[3-(5-nitro-2-furyl)-2-thiazolyl]formamide. | 1967 | 99 |
| 3 | 1973 | 69 | |
| 4 | 2019 | 44 | |
| 5 | 2016 | 41 | |
| 6 | 2019 | 28 | |
| 7 | 2017 | 27 | |
| 8 | 1985 | 26 | |
| 9 | 1971 | 20 | |
| 10 | 2009 | 17 | |
| 11 | 1972 | 16 | |
| 12 | The production of hemangioendothelialsarcoma in rats by feeding 5-acetamido-3-(5-nitro-2-furyl)-6H-1,2,4-oxadiazine. | 1969 | 14 |
| 13 | 2021 | 9 | |
| 14 | 1988 | 4 | |
| 15 | 2012 | 3 | |
| 16 | 2017 | 2 | |
| 17 | 1988 | 2 | |
| 18 | 2016 | 2 | |
| 19 | 2015 | 1 | |
| 20 | 2016 | 1 |
About Amanda Esch
Amanda Esch is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Epidemiology and Genetics, having authored 20 papers that have together received 531 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (2 papers), Synthesis and biological activity (2 papers), PARP inhibition in cancer therapy (2 papers), Estrogen and related hormone effects (2 papers), Synthesis and Characterization of Heterocyclic Compounds (2 papers), DNA Repair Mechanisms (1 paper), Ubiquitin and proteasome pathways (1 paper) and BRCA gene mutations in cancer (1 paper). The work is most often cited by research in Oncology (124 citations), Biophysics (29 citations), Cancer Research (54 citations), Epidemiology (110 citations) and Biochemistry (23 citations). Amanda Esch has collaborated with scholars based in United States, United Kingdom and Greece. Frequent co-authors include N. L. Shipkowitz, A. Crovetti, Lacy R. Overby, J. B. Schleicher, E Ertürk, J. M. Price, William R. Roderick, Carl W. Nordeen, Robert R. Bower and Laura M. Heiser. Their work appears in journals such as European Journal of Endocrinology, Cancer Research, Molecular Cancer Therapeutics, Protein Expression and Purification and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.